Role of autophagy and other downstream effectors in lifespan extension by teh GCN4/ATF4 pahtway
自噬和其他下游效应子在 GCN4/ATF4 途径延长寿命中的作用
基本信息
- 批准号:10249122
- 负责人:
- 金额:$ 27.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAgingAlzheimer&aposs DiseaseAnalysis of VarianceAnimal ModelAnimalsAutophagocytosisCaloric RestrictionDataDependenceDiseaseDistantDrug TargetingGenetic TranscriptionGoalsHuman BiologyIGF1 geneInflammationInsulinInterventionLightLongevityMalignant NeoplasmsMeasurementMeasuresMediatingMetabolismMitochondriaModelingOutputPathway interactionsPhenotypePlayPreventionPrevention approachProteinsResearchRoleSignal TransductionTestingTranscriptValidationYeastsactivating transcription factordesignexperimental studyhuman diseaseinnovationnovelprotein degradationtranscription factortranscriptome sequencing
项目摘要
We now know multiple pathways that delay aging, and have extended the lifespan of some animals by as
much as 10-fold, yet we do not fully understand the final mechanistic effectors of delayed aging in any example
to date. Thus we do not know the underlying changes involved in natural aging, presumably offset or delayed
by our interventions. The long-term goal is to is to understand the most downstream changes in delayed aging.
This will allow a rational approach to developing interventions to broadly delay the onset of multiple human
diseases of aging such as Alzheimer’s disease and cancer. The overall objective in this application, the next
step in pursuit of that long-term goal, is to understand downstream effectors of delayed aging specifically in the
novel Gcn4 pathway. The central hypothesis is that targets of conserved transcription factor Gcn4 are the likely
effectors, that the most relevant of these will be shared by multiple distinct Gcn4-dependent interventions, and
that autophagy and increased protein turnover are likely to play a key role. The rationale for the proposed
research is two-fold: 1) once we know the effectors of Gcn4-mediated delayed aging, they can be directly
manipulated, giving approaches for prevention and treatment of human diseases of aging; 2) A functionally
validated set of effectors allows us to ask if these are shared by other pathways, and will also shed light on the
changes that underly natural aging. Guided by our preliminary data, this will be tested by pursuing three
specific aims: 1) Determine the Gcn4-dependence of mitochondrial translational deletions; 2) Determine the
role of autophagy in Gcn4-mediated delayed aging; and 3) Identify and validate the most functionally relevant
transcriptional targets of Gcn4 / ATF-5. In part of the second aim we will use the UNM AIM CoBRE Core Amnis
Imagestream to simultaneously measure the age, autophagy level, and Gcn4 protein level of thousands of
yeast. The approach is innovative, in the applicant’s opinion, because it represents a new and substantive
departure from the status quo byassaying transcriptional output following multiple distinct interventions
dependent on the same transcription factor, using a novel block design RNAseq-ANOVA model of changes in
transcript levels, in order to focus specifically on those transcriptional changes tied to our phenotype of delayed
aging while excluding others. It also uses validation through lifespan measurements experiments in two
distantly related model organisms, to ask which changes are most conserved, and thus most likely to be
relevant to human biology. The proposed research is significant, because a fuller understanding of the
downstream effectors of delayed aging will identify drug targets with translational importance in the prevention
and treatment of multiple human diseases of aging. The potential impact of these findings is underscored by
the fact that we cannot now preclude the possibility that multiple known pathways that delay aging, such as
caloric restriction, Insulin / IGF1 signaling, and TOR, all effect their phenotype largely through changes in
autophagy, nor can we rule out that all of these pathways do this in some part by converging on Gcn4.
我们现在知道了多种延缓衰老的途径,并延长了一些动物的寿命
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark McCormick其他文献
Mark McCormick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark McCormick', 18)}}的其他基金
Role of autophagy and other downstream effectors in lifespan extension by teh GCN4/ATF4 pahtway
自噬和其他下游效应子在 GCN4/ATF4 途径延长寿命中的作用
- 批准号:
10248579 - 财政年份:2018
- 资助金额:
$ 27.79万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 27.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)